BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27879966)

  • 1. Andrological complications following retroperitoneal lymph node dissection for testicular cancer.
    Crestani A; Esperto F; Rossanese M; Giannarini G; Nicolai N; Ficarra V
    Minerva Urol Nefrol; 2017 Jun; 69(3):209-219. PubMed ID: 27879966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
    Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
    Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.
    Cheney SM; Andrews PE; Leibovich BC; Castle EP
    BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nerve preserving retroperitoneal lymph node excision in non-seminomatous testicular cancer].
    Hofmann R; Hartung R; von Stauffenberg A
    Urologe A; 1994 Jan; 33(1):38-43. PubMed ID: 8146929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
    Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
    Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
    Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
    World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor.
    Mistretta FA; de Cobelli O; Verze P; Botticelli F; Jannello L; Luzzago S; Cozzi G; Bianchi R; Di Trapani E; Ferro M; Cordima G; Bottero D; Matei DV; Mirone V; Musi G
    Asian J Androl; 2022; 24(6):579-583. PubMed ID: 35381697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.
    Pettus JA; Carver BS; Masterson T; Stasi J; Sheinfeld J
    Urology; 2009 Feb; 73(2):328-31; discussion 331-2. PubMed ID: 19022490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.
    Williams SB; McDermott DW; Winston D; Bahnson E; Berry AM; Steele GS; Richie JP
    BJU Int; 2010 Apr; 105(7):918-21. PubMed ID: 19747353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.